NCT02689089 - Taima TB: 3HP Study | Biotech Hunter

Enrollment

182

Participants

Timeline

Start Date

November 28, 2016

Primary Completion Date

August 15, 2019

Study Completion Date

August 15, 2019

Conditions

Tuberculosis

Interventions

DRUG

3HP

An interrupted time series study design will be used to determine if the introduction of the 3HP regimen will result in more people completing LTBI treatment compared to the standard of 9 months INH twice weekly.

Trial Locations (1)

K1H 8L6

The Ottawa Hospital - General Campus, Ottawa